Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan's MHLW Calls Attention To Liver Failure Associated With Tamiflu

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare reported cases of fulminate hepatic failure associated with flu drug Tamiflu. According to Chugai Pharmaceuticals, Tamiflu's importer and distributor in Japan, two deaths from fulminate hepatic failure after taking Tamiflu were reported since the market launch of the drug in 2001. MHLW also requested a warning label change to Tamiflu. (Click here for more - Japanese language) "MHLW Calls Attentions To Fulminate Hepatic Failure Caused By Taking Tamiflu" - Yomiuri News (3/1/08)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts